Novel Myocardial PET/CT Receptor Imaging and Potential Therapeutic Targets

Novel Myocardial PET/CT Receptor Imaging and Potential Therapeutic Targets Purpose of the Review Activation of myocardial cannabinoid type 1 receptors (CB1-R) and/or angiotensin II type 1 receptors (AT1-R) likely plays an important mechanistic role in determining the left-ventricular remodeling process in systolic heart failure. We provide an overview on novel radiotracer probes and positron emission tomography (PET)/computed tomography (CT) imaging to noninvasively probe the expression of myocardial CB1-R and/or AT1-R. 11 11 Recent Findings Recent translational investigations have demonstrated the feasibility of C-OMAR or C-KR31173 and PET/ CT to image and quantify myocardial CB1-R and/or AT1-R expression, respectively. There is an increasing understanding of the mechanisms of activated myocardial CB1-R and/or AT1-R to influence the left-ventricular remodeling process in systolic heart failure in different disease entities. Summary The review summarizes contributions of PET to image myocardial CB1-R and AT1-R expression that may have the potential to serve as a target to tailor preventive medical care in the individual patient. . . . . Keywords Angiotensin II type 1 receptors Angiotensin-converting enzyme Cannabinoid type 1 receptor Heart failure . . Left-ventricular remodeling Obesity Positron emission tomography Introduction The continuous steady increase in the prevalence of obesity in industrialized nations has reached a level as high as ∼ 30%. This http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Cardiology Reports Springer Journals

Novel Myocardial PET/CT Receptor Imaging and Potential Therapeutic Targets

Loading next page...
 
/lp/springer-journals/novel-myocardial-pet-ct-receptor-imaging-and-potential-therapeutic-sYumdsRQaZ
Publisher
Springer Journals
Copyright
Copyright © 2019 by Springer Science+Business Media, LLC, part of Springer Nature
Subject
Medicine & Public Health; Cardiology
ISSN
1523-3782
eISSN
1534-3170
D.O.I.
10.1007/s11886-019-1148-2
Publisher site
See Article on Publisher Site

Abstract

Purpose of the Review Activation of myocardial cannabinoid type 1 receptors (CB1-R) and/or angiotensin II type 1 receptors (AT1-R) likely plays an important mechanistic role in determining the left-ventricular remodeling process in systolic heart failure. We provide an overview on novel radiotracer probes and positron emission tomography (PET)/computed tomography (CT) imaging to noninvasively probe the expression of myocardial CB1-R and/or AT1-R. 11 11 Recent Findings Recent translational investigations have demonstrated the feasibility of C-OMAR or C-KR31173 and PET/ CT to image and quantify myocardial CB1-R and/or AT1-R expression, respectively. There is an increasing understanding of the mechanisms of activated myocardial CB1-R and/or AT1-R to influence the left-ventricular remodeling process in systolic heart failure in different disease entities. Summary The review summarizes contributions of PET to image myocardial CB1-R and AT1-R expression that may have the potential to serve as a target to tailor preventive medical care in the individual patient. . . . . Keywords Angiotensin II type 1 receptors Angiotensin-converting enzyme Cannabinoid type 1 receptor Heart failure . . Left-ventricular remodeling Obesity Positron emission tomography Introduction The continuous steady increase in the prevalence of obesity in industrialized nations has reached a level as high as ∼ 30%. This

Journal

Current Cardiology ReportsSpringer Journals

Published: May 18, 2019

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off